Sarcoma, Kaposi: all 162 studies
Page 1 of 2. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.
- Disease Evolution and Risk Factors of AIDS-related Prevalent CancersNot yet recruitingNCT07696169
- Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialNot yet recruitingNCT07576725Phase 2
- Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)RecruitingNCT07308886Phase 2
- Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced SarcomasRecruitingNCT07066982Phase 1/2
- Precision Imaging to Evaluate Kaposi SarcomaRecruitingNCT06898203Not applicable
- Precision Imaging to Evaluate Kaposi Sarcoma (PRIME-KS): A Device Feasibility TrialRecruitingNCT06751355
- Propranolol for the Treatment of Kaposi Sarcoma in AdultsRecruitingNCT06445166Phase 2
- Natural History Study of Kaposi SarcomaRecruitingNCT06375122
- The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated VirusRecruitingNCT06236022Phase 4
- AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)RecruitingNCT06004011Not applicable
- Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman DiseaseRecruitingNCT05907759Phase 2
- A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor CancerRecruitingNCT05859074Phase 1
- A Study of Propranolol to Treat Kaposi SarcomaRecruitingNCT05797662Phase 2
- Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related CancersRecruitingNCT05663502
- Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi SarcomaNot yet recruitingNCT05411237Phase 3
- L19IL2/L19TNF in Skin Cancer PatientsRecruitingNCT05329792Phase 2
- Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform HemangioendotheliomaRecruitingNCT05324384Phase 2
- HHV8 and Solid Organ TransplantationRecruitingNCT05081141
- Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi SarcomaRecruitingNCT04941274Phase 1/2
- Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIVRecruitingNCT04902443Phase 1
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue NeoplasiaRecruitingNCT04534127Not applicable
- Trial of Ixazomib for Kaposi SarcomaRecruitingNCT04305691Phase 2
- PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi SarcomaRecruitingNCT04303117Phase 1/2
- Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted AngiomaRecruitingNCT04056962Phase 2
- A Study of sEphB4-HSA in Kaposi SarcomaRecruitingNCT03993106Phase 2
- Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.RecruitingNCT03889899Not applicable
- Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman DiseaseRecruitingNCT03300830
- Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and CancerRecruitingNCT00006518
- Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMCCompletedNCT05510908Results posted
- NT-I7 for Kaposi Sarcoma in Patients With or Without HIVTerminatedNCT04893018Phase 1Results posted
- Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVActive, not recruitingNCT04514484Phase 1Results posted
- Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.CompletedNCT03296553Phase 2Results posted
- An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)CompletedNCT03157167Phase 1Results posted
- Nelfinavir Mesylate in Treating Patients With Kaposi SarcomaCompletedNCT03077451Phase 2Results posted
- Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerCompletedNCT02595866Phase 1Results posted
- Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryTerminatedNCT02408861Phase 1Results posted
- Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CTCompletedNCT02201420Phase 2Results posted
- A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular TumorsTerminatedNCT02110069Phase 2Results posted
- A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's SarcomaCompletedNCT02029430Phase 2Results posted
- Pomalidomide for Kaposi Sarcoma in People With or Without HIVCompletedNCT01495598Phase 1/2Results posted
- Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's SarcomaCompletedNCT01352117Phase 3Results posted
- Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral CavityCompletedNCT01296815Phase 2Results posted
- Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)CompletedNCT01276236Phase 2Results posted
- Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaCompletedNCT01154452Phase 1/2Results posted
- Lenalidomide in Treating Patients With AIDS-Associated Kaposi's SarcomaCompletedNCT01057121Phase 1/2Results posted
- Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s SarcomaCompletedNCT00923936Phase 2Results posted
- PTC299 in Treating Patients With HIV-Related Kaposi SarcomaTerminatedNCT00686842Phase 1/2Results posted
- Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's SarcomaCompletedNCT00096538Not applicableResults posted
- Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's SarcomaCompletedNCT00090987Phase 2Results posted
- Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative PatientsCompletedNCT00055237Phase 2Results posted
- Assessment of Blood Vessel Density in Kaposi's Sarcoma LesionsCompletedNCT00026793Results posted
- Agnostic Therapy in Rare Solid TumorsActive, not recruitingNCT06638931Phase 2
- Kaposi Sarcoma Chemotherapy and Research (KS-CARE)Active, not recruitingNCT06480773
- Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi SarcomaWithdrawnNCT05846724Phase 2
- Doxil/Caelyx BE StudyCompletedNCT05567601Phase 1
- Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.CompletedNCT04775173Phase 2
- Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal AnalysisActive, not recruitingNCT04742387
- Retreatment With Intratumoral Diffusing Alpha Radiation EmittersCompletedNCT04540588Not applicable
- Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform HemangioendotheliomaCompletedNCT04448873Phase 4
- SCMC Trial on KHE With KMP (V.2020)Status unknownNCT04409691Phase 1
- Safety and Efficacy of Low-dose Sirolimus to Kaposiform HemangioendotheliomaCompletedNCT04077515Phase 4
- Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi SarcomaStatus unknownNCT04065152Phase 2
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
- Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)TerminatedNCT03886181Not applicable
- Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)Active, not recruitingNCT03737734Not applicable
- Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's SarcomaStatus unknownNCT03469804Phase 2
- Compression Therapy for Leg Ulcers and Kaposi Sarcoma in Western KenyaCompletedNCT03404297Not applicable
- Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi SarcomaCompletedNCT03316274Early Phase 1
- Nivolumab and Ipilimumab in Classical Kaposi Sarcoma (CKS)Status unknownNCT03219671Phase 2
- Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform HemangioendotheliomaCompletedNCT03188068Phase 2
- Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in MalawiCompletedNCT03160183
- Smartphone Confocal Microscopy for Diagnosing Kaposi's SarcomaCompletedNCT03050788Not applicable
- Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi SarcomaActive, not recruitingNCT02659930Phase 1
- Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi SarcomaWithdrawnNCT02229981Phase 1/2
- Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi SarcomaWithdrawnNCT02137564Phase 2
- Nelfinavir for the Treatment of Gammaherpesvirus-Related TumorsTerminatedNCT02080416Early Phase 1
- Strategies to Improve Kaposi Sarcoma (KS) Outcomes in ZimbabweCompletedNCT01764360Not applicable
- A Study of Selumetinib in Patients With Kaposi's SarcomaTerminatedNCT01752569Phase 1/2
- A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's SarcomaTerminatedNCT01412515Phase 2
- Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's SarcomaCompletedNCT01067690Phase 2
- Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi SarcomaCompletedNCT01016730Phase 1
- 124I-FIAU Imaging in EBV and KSHV Associated CancersCompletedNCT00982449Not applicable
- A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in ZimbabweCompletedNCT00834457Phase 2/3
- AIDS and Cancer Specimen Bank (ACSB)CompletedNCT00587912
- Spectroscopy With Surface Coils and DecouplingCompletedNCT00581815Phase 1
- Optical Biopsy of Human Skin in Conjunction With Laser TreatmentCompletedNCT00540566
- Sunitinib Malate in Treating East African Patients With Kaposi SarcomaWithdrawnNCT00521092Phase 2
- Sirolimus in Treating Patients With HIV-Related Kaposi's SarcomaCompletedNCT00450320Phase 1
- Anti-Retrovirals for Kaposi's SarcomaCompletedNCT00444379Phase 4
- Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's SarcomaTerminatedNCT00427414Phase 1
- Development of Serologic Assays for Human Herpes Virus-8CompletedNCT00395278
- HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXTCompletedNCT00380770Phase 4
- Treatment of Classical Non-HIV-Related Kaposi's Sarcoma With the Antiviral Drug IndinavirCompletedNCT00362310Phase 2
- Studies of Human Herpesvirus 8 and Kaposi's Sarcoma in SicilyCompletedNCT00339937
- Risk Factors for Non-HIV-Related Kaposi s SarcomaCompletedNCT00339326
- Nicotine Skin Patch in Treating Patients With Kaposi's SarcomaCompletedNCT00295984Phase 2
- BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's SarcomaTerminatedNCT00287495Phase 1
- Infrared Thermography in Finding Skin Lesions in Patients With Kaposi's SarcomaTerminatedNCT00265902Not applicable
- Valproic Acid in Treating Patients With Kaposi's SarcomaCompletedNCT00075777Not applicable
- Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's SarcomaCompletedNCT00064142Phase 2